![Richard M. Pinnola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard M. Pinnola
Chief Executive Officer at
NeoDiagnostix, Inc.
Profile
Richard M.
Pinnola is currently the President & Chief Executive Officer at NeoDiagnostix, Inc. He previously held positions as Vice President-Marketing & Commercial Development at Becton, Dickinson & Co., Chief Operating Officer at LipoScience, Inc., and Principal at Roche Molecular Systems, Inc. Pinnola received his undergraduate degree from New York University.
Richard M. Pinnola active positions
| Companies | Position | Start |
|---|---|---|
NeoDiagnostix, Inc.
 NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostic and prognostic tests for the treatment of cancer | Chief Executive Officer | 2010-02-15 |
Former positions of Richard M. Pinnola
| Companies | Position | End |
|---|---|---|
| BECTON, DICKINSON AND COMPANY | Sales & Marketing | - |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Corporate Officer/Principal | - |
| LIPOSCIENCE INC | Chief Operating Officer | - |
Training of Richard M. Pinnola
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
LipoScience, Inc.
 LipoScience, Inc. Medical SpecialtiesHealth Technology Operates as an in vitro diagnostic company for cardiovascular and metabolic diseases using technology platform based on nuclear magnetic resonance | Health Technology |
NeoDiagnostix, Inc.
NeoDiagnostix, Inc. Medical/Nursing ServicesHealth Services Develops molecular diagnostic and prognostic tests for the treatment of cancer | Health Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
- Stock Market
- Insiders
- Richard M. Pinnola
